Anti-phosphatidylserine-prothrombine complex antibodies in patients with localized scleroderma

Clinical and Experimental Rheumatology

Volumn 24, Issue 1, 2006, Pages 19-24

  Hasegawa, Minoru ^a   Fujimoto, Manabu ^a   Hayakawa, Ikuko ^a   Matsushita, Takashi ^a   Nishijima, Chihiro ^a   Yamazaki, Masahide ^a   Takehara, Kazuhiko ^a   Sato, Shinichi ^b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Antiphospholipid antibody; Localized scleroderma; Thromboembolism

Indexed keywords

PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; PROTHROMBIN COMPLEX; AUTOANTIBODY; IMMUNOGLOBULIN G; PROTHROMBIN;

AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; BRAIN INFARCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LOCALIZED SCLERODERMA; LUNG INFARCTION; MALE; MORPHEA; PRESCHOOL CHILD; PRIORITY JOURNAL; PSORIASIS VULGARIS; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOEMBOLISM; ADOLESCENT; ADULT; ANTIGEN ANTIBODY COMPLEX; BLOOD; CHILD; FEMALE; IMMUNOLOGY; LUNG EMBOLISM; METABOLISM; MIDDLE AGED; PSORIASIS;

ADOLESCENT; ADULT; AGED; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PHOSPHATIDYLSERINES; PROTHROMBIN; PSORIASIS; PULMONARY EMBOLISM; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC;

EID: 33645049578     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. TUFFANELLI DL, WINKELMANN RK: Systemic scleroderma. Arch Dermatol 1961; 84: 359-71.
2. TAKEHARA K, MOROI Y, NAKABAYASHI Y, ISHIBASHI Y: Antinuclear antibodies in localized scleroderma. Arthritis Rheum 1983; 26: 612-6.
3. FALANGA V, MEDSGER TA Jr, REICHLIN M, RODNAN GP: Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 1986; 104: 849-57.
4. TAKEHARA K, KIKUCHI K, SOMA Y, IGARASHI A, ISHIBASHI Y: Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma. Arch Dermatol 1990; 126: 1368.
5. SATO S, IHN H, SOMA Y et al.: Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 1993; 36: 1137-41.
6. SATO S, FUJIMOTO M, IHN H, KIKUCHI K, TAKEHARA K: Antigen specificity of antihistone antibodies in localized scleroderma. Arch Dermatol 1994; 130: 1273-7.
7. HARRIS EN, CHAN JK, ASHERSON RA, ABER VR, GHARAVI AE, HUGHES GR: Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153-6.
8. WILSON WA, GHARAVI AE, KOIKE T et al.: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-11.
9. GALLI M, LUCIANI D, BERTOLINI G, BARBUI T: Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003; 102: 2717-23.
10. ATSUMI T, IEKO M, BERTOLACCINI ML et al.: Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000; 43: 1982-93.
11. AMENGUAL O, ATSUMI T, KOIKE T: Specificities, properties, and clinical significance of antiprothrombin antibodies. Arthritis Rheum 2003; 48: 886-95.
12. SATO S, FUJIMOTO M, HASEGAWA M, TAKEHARA K: Antiphospholipid antibody in localised scleroderma. Ann Rheum Dis 2003; 62: 771-4.
13. SATO S, FUJIMOTO M, IHN H, KIKUCHI K, TAKEHARA K: Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad. Dermatol 1994; 31: 567-71.
14. BRANDT JT, TRIPLETT DA, ALVING B, SCHARRER I: Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
15. SATO S, IHN H, KIKUCHI K, TAKEHARA K: Antihistone antibodies in systemic sclerosis: association with pulmonary fibrosis. Arthritis Rheum t994; 37: 391-4.
16. HAYAKAWA I, HASEGAWA M, TAKEHARA K, SATO S: Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma. Arthritis Rheum 2004; 50: 227-32.
17. SATO S KM, HASEGAWA M, FUJIMOTO M, TAKAHARA K: Anti-nucleosome antibody is a major auoantibody in localized scleroderma. Br J Dermatol 2004; in press.
18. SGONC R, GRUSCHWITZ MS, DIETRICH H, RECHEIS H, ERIC GRESHWIN M, WICK G: Endothelial cell apoptosis is a primary pathogeneic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996; 98: 785-92.
19. RUDEL T, BOKOCH GM: Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997; 276: 1571-4.
20. D'AGNILLO P, LEVINE JS, SUBANG R, RAUCH J: Prothrombin binds to the surface of apoptotic, but not viable, cells and serves as a target of lupus anticoagulant autoantibodies. J Immunol 2003; 170: 3408-22.
21. PRICE BE, RAUCH J, SHIA MA et al.: Antiphospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-gly-coprotein I-dependent manner. J Immunol 1996; 157: 2201-8.
22. LEVINE JS, SUBANG R, KOH JS, RAUCH J: Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes. J Autoimmun 1998; 11: 413-24.
23. FREEMAN WE, LESHER Jr JL, SMITH Jr JG: Connective tissue disease associated with sclerodermoid features, early abortion, and circulating anticoagulant. J Am Acad Dermatol 1988; 19: 932-6.
24. CASTANET J, LACOUR J Ph, PERRIN C, TAILLAN B, DUBOIS D, ORTONNE JP: Association of eosinophilic fasciitis, multiple morphea and antiphospholipid antibody. Dermatology 1994; 189: 304-7.
25. FLECK RA, RAPAPORT SI, RAO LV: Antiprothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-9.
26. CERVERA R, PIETTE JC, FONT J et al.: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-27.
27. KABURAKI J, KUWANA M, UEHARA R et al.: Development of ELISA kit to examine anti-phosphatidylserine/prothrombin complex antibodies. Jpn J Med Pharmaceutical Sci 2002; 47: 813-9.
28. KABURAKI J, KUWANA M, IKEDA Y: Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in the diagnosis of anti-phospholipid syndrome. Jpn J Clin Hematol 2003; 44: 28-30.
29. KABURAKI J, KUWANA M, KAMEDA H et al.: Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in antiphospholipid syndrome. Jpn J Clin Hematol 2005; 46: 19-21.